Related Experiment Video
Updated: May 12, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Lassa and Mopeia viruses produce different RIG-I-activating RNA in the absence of a functional viral exoribonuclease
Kodie Noy1,2, Rachel Legendre3, Séverine Croze4
1Biology of Viral Emerging Infections Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Abstract:
All viruses of the genus Mammarenavirus possess an exoribonuclease (ExoN) domain in their nucleoproteins (NP). Through this domain, the NP efficiently prevents the activation of the interferon (IFN) response, presumably by degrading double-stranded RNA (dsRNA) produced during the viral replication. While the importance of this ExoN activity regarding Mammarenavirus virulence is well established, little is known about the dsRNA molecules that are targeted by NP for degradation, and the contribution of cellular sensors activated by these molecules has yet to be described. Here, we addressed these questions using recombinant viruses with abrogated ExoN domains that are no longer able to control the IFN response. We infected RIG-I, MDA5, and MAVS deficient cells and demonstrated that ExoN mutants activate the interferon response through RIG-I, but not MDA5. We then purified RIG-I-associated RNA from infected cells and confirmed its immunostimulatory activity in transfected cells. We sequenced the RIG-I-associated RNA and identified different enriched sequences in the Mopeia virus (MOPV) or Lassa virus (LASV) RNA. RIG-I activating sequences corresponded to the extremities of the 5' ends and intergenic regions of the MOPV genome and to a glycoprotein precursor complex (GPC) sequence in the LASV genome. We produced corresponding synthetic RNA molecules and confirmed their RIG-I-dependent activation of the IFN response. These results underline the central role of the ExoN domain in MOPV and LASV NP for immune escape and identify new virus-derived RNA molecules with high immunostimulatory properties.IMPORTANCEArenaviruses prevent the activation of the interferon response due to the exonuclease activity of their nucleoprotein, suggesting that infection leads to the production of immunostimulatory RNA molecules. However, neither the exact nature of the immune RNA sensors nor the identity of the RNA activating these sensors is clearly identified. By taking advantage of recombinant MOPV and LASV deficient for their exonuclease activity and that are strong activators of the interferon response, we have identified RIG-I as the major sensor of arenaviruses in infected cells. We also identified the RNA molecules recognized by RIG-I upon infection, and we highlighted differences between MOPV and LASV viruses. Our results represent critical information regarding the factors of immunogenicity and pathogenicity of Old-World arenaviruses and can help us explain key differences between pathogenic and non-pathogenic arenaviruses.
Insights
Mammarenavirus nucleoproteins use exonuclease activity to evade the interferon response by degrading viral RNA. This study identifies RIG-I as the key sensor for these RNA molecules, revealing differences between Mopeia and Lassa viruses.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Mammarenavirus nucleoproteins (NP) possess an exoribonuclease (ExoN) domain crucial for preventing host interferon (IFN) responses, likely via double-stranded RNA (dsRNA) degradation.
- The specific dsRNA targets and cellular sensors involved in this immune evasion remain largely unidentified, hindering understanding of viral virulence.
Purpose of the Study:
- To identify the cellular sensors activated by viral RNA in the absence of ExoN activity.
- To characterize the specific viral RNA molecules that trigger these sensors.
- To elucidate the role of the ExoN domain in viral immune evasion strategies of Mopeia virus (MOPV) and Lassa virus (LASV).
Main Methods:
- Utilized recombinant MOPV and LASV with abrogated ExoN domains to study IFN activation.
- Infected cells deficient in RIG-I, MDA5, and MAVS to determine the primary RNA sensor.
- Purified RIG-I-associated RNA and sequenced it to identify specific viral RNA motifs.
- Synthesized RNA molecules corresponding to identified motifs to confirm RIG-I activation.
Main Results:
- ExoN-deficient viruses activated the IFN response primarily through RIG-I, not MDA5.
- Sequencing identified specific MOPV 5' end and intergenic region sequences, and LASV glycoprotein precursor complex (GPC) sequences as RIG-I activators.
- Synthetic RNA molecules corresponding to these sequences confirmed their ability to induce RIG-I-dependent IFN activation.
Conclusions:
- The ExoN domain of MOPV and LASV nucleoproteins is critical for immune evasion by limiting the recognition of specific viral RNA structures by RIG-I.
- Identified novel virus-derived RNA molecules with potent immunostimulatory properties, contributing to arenavirus immunogenicity and pathogenicity.
- Highlights key differences in RNA recognition between MOPV and LASV, offering insights into Old-World arenavirus pathogenesis.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
06:44Confocal Imaging of Double-Stranded RNA and Pattern Recognition Receptors in Negative-Sense RNA Virus Infection
Published on: January 26, 2019
Related Concept Videos
Viruses with RNA Genomes
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...
Leaky Scanning
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...